Summary of Estudo brasileiro promete erradicar superbactérias resistentes a antibióticos

00:00:00 - 00:00:00

Researchers from Universidade Federal de São Carlos, Universidade Estadual Paulista, and Instituto Federal de Educação Ciência e Tecnologia do Maranhão, funded by Fapesp, have discovered that nanoparticles can inactivate superbacterias resistant to antibiotics in a study published in the journal of chemical engineering environmental science. This finding, which will aid in controlling bacteria that thrive in hospitals, can be used in coatings, solar protectors, creams, and water treatment in the form of powder. The safety of using this material is the next focus, with tests estimated to be completed in two years. Antibiotics have saved countless lives since the early 20th century, but the emergence of superbacterias resistant to all current medicaments poses a significant public health concern, with at least 5 million deaths annually linked to antimicrobial resistance according to the World Health Organization. In Brazil, over 33,000 people died from multidrug-resistant bacteria in 2019, as reported by the Ministry of Health. Hospitals are particularly susceptible to the spread of these superbacterias, necessitating urgent research to combat them.

• 00:00:00 In this section of the YouTube video titled "Estudo brasileiro promete erradicar superbactérias resistentes a antibióticos," researchers from the Universidade Federal de São Carlos, Universidade Estadual Paulista, and Instituto Federal de Educação Ciência e Tecnologia do Maranhão, with funding from Fapesp, have identified that nanoparticles, or very small metallic or metal oxide particles, have the ability to inactivate these microorganisms. This research, published in the journal of chemical engineering environmental science this week, will help control bacteria that proliferate in hospitals. The researchers plan to use this material in coatings, solar protectors, or creams for external use, and in the form of powder for water treatment. The next steps of the research involve ensuring the safety of using this material, and the estimation is that the tests will be completed in two years. The difference between the remedy and the poison lies in the dose. While antibiotics have saved thousands of lives since the beginning of the 20th century, the emergence of superbacterias resistant to all medicaments created so far is a major public health issue. At least 5 million deaths per year are linked to antimicrobial resistance, according to the World Health Organization. In Brazil, these multidrug-resistant bacteria killed at least 33,000 people in 2019, according to the Ministry of Health. Hospitals are the most susceptible to the dissemination of these superbacterias, leading to an increasing need for faster studies to control them.